LXR activation inhibits chemokine-induced CD4-positive lymphocyte migration


Migration of CD4-positive lymphocytes into the vessel wall is a critical step in atherogenesis. Recent data suggest that CD4-positive lymphocytes express the nuclear transcription factors Liver-X-Receptor (LXR) alpha and beta with an effect of LXR activators on TH1-cytokine release from these cells. However, the role of LXR in lymphocyte migration remains currently unexplored. Therefore, the present study investigated whether LXR activation might modulate chemokine-induced migration of these cells. Stimulation of CD4-positive lymphocytes with SDF-1 leads to a 2.5 ± 0.8-fold increase in cell migration (P < 0.05; n = 12). Pretreatment of cells with the LXR activator T0901317 reduces this effect in a concentration-dependent manner to a maximal 0.9 ± 0.4-fold induction at 1 μmol/L T0901317 (P < 0.05 compared to SDF-1-treated cells; n = 12). Similar results were obtained with the LXR activator GW3965. The effect of LXR activators on CD4-positive lymphocyte migration was mediated through an early inhibition of chemokine-induced PI-3 kinase activity as determined by PI-3 kinase activity assays. Downstream, T0901317 inhibited activation of the small GTPase Rac and phosphorylation of the myosin light chain (MLC). Moreover, LXR activator treatment reduced f-actin formation as well as ICAM3 translocation to the uropod of the cell, thus interfering with two important steps in T cell migration. Transfection of CD4-positive lymphocytes with LXRα/β siRNA abolished T0901317 inhibitory effect on MLC phosphorylation and ICAM3 translocation. LXR activation by T0901317 or GW3965 inhibits chemokine-induced migration of CD4-positive lymphocytes. Given the crucial importance of chemokine-induced T cell migration in early atherogenesis, LXR activators may be promising tools to modulate this effect.

DOI: 10.1007/s00395-010-0092-5

5 Figures and Tables

Citations per Year

1,204 Citations

Semantic Scholar estimates that this publication has 1,204 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Walcher2010LXRAI, title={LXR activation inhibits chemokine-induced CD4-positive lymphocyte migration}, author={Daniel Walcher and Dusica Vasic and Philipp Heinz and Helga Bach and Renate Durst and Angelina Hausauer and V. Hombach and Nikolaus Marx}, journal={Basic Research in Cardiology}, year={2010}, volume={105}, pages={487-494} }